These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 149781

  • 21. Effect of neocarzinostatin on microtubules.
    Satake M, Ebina T, Ishida N.
    Gan; 1979 Aug; 70(4):545-8. PubMed ID: 159849
    [Abstract] [Full Text] [Related]

  • 22. Stabilization of neocarzinostatin nonprotein chromophore activity by interaction with apoprotein and with HeLa cells.
    Kappen LS, Goldberg IH.
    Biochemistry; 1980 Oct 14; 19(21):4786-90. PubMed ID: 6448635
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
    Suzuki F, Pollard RB, Uchimura S, Munakata T, Maeda H.
    Cancer Res; 1990 Jul 01; 50(13):3897-904. PubMed ID: 2141295
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neocarzinostatin induction of DNA repair synthesis in HeLa cells and isolated nuclei.
    Kappen LS, Goldberg IH.
    Biochim Biophys Acta; 1978 Oct 24; 520(3):481-9. PubMed ID: 152651
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Antitumor activity of macromomycin].
    Kato T, Yamanaka N, Katayama S, Mizutani M, Ota K.
    Gan To Kagaku Ryoho; 1982 Jul 24; 9(6):1097-101. PubMed ID: 7184442
    [Abstract] [Full Text] [Related]

  • 33. The biologically active site of neocarzinostatin-chromophore.
    Koide Y, Ito A, Edo K, Ishida N.
    Chem Pharm Bull (Tokyo); 1986 Oct 24; 34(10):4425-8. PubMed ID: 2951017
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of blood, ascites, and tumor cell density on cytocidal action of neocarzinostatin.
    Shimoyama M, Kimura K.
    Gan; 1979 Apr 24; 70(2):165-71. PubMed ID: 157307
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Action mechanisms of zinostatin stimalamer (YM881)].
    Tanaka S, Numasaki Y, Maeda H.
    Gan To Kagaku Ryoho; 1991 Oct 24; 18(13):2295-300. PubMed ID: 1834022
    [Abstract] [Full Text] [Related]

  • 39. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
    Oda T, Sato F, Yamamoto H, Akagi M, Maeda H.
    Anticancer Res; 1989 Oct 24; 9(2):261-5. PubMed ID: 2526613
    [Abstract] [Full Text] [Related]

  • 40. Clinical investigations of neocarzinostatin in Japan.
    Kimura I.
    Recent Results Cancer Res; 1978 Oct 24; 63():252-60. PubMed ID: 151899
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.